A single-arm phase II trial of <i>UGT1A1</i> genotype-guided high-dose irinotecan rechallenge in refractory metastatic colorectal cancer. [PDF]
Kim H, Hong J, Kong SY, Choi MK.
europepmc +1 more source
UGT1A1 and irinotecan: Ready for routine pharmacogenetic care. [PDF]
Swen JJ.
europepmc +1 more source
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). [PDF]
Chauhan D +24 more
europepmc +1 more source
Analytical validation of a high-resolution melting assay for UGT1A1 TATA-box polymorphisms. [PDF]
Gambarino S +6 more
europepmc +1 more source
The inhibitory effect of 20(S)-protopanaxatriol (Ppt) towards UGT1A1 and UGT2B7 indicating a risk for UGT inhibition-based herb-drug ...
房中则 +6 more
core
UGT1A1 polymorphisms and gallbladder-related outcomes in sickle cell disease in Brazil. [PDF]
Costa FF, Fertrin KY.
europepmc +1 more source
Development of a PCR-based technique for genotyping UGT1A1 gene and distribution of rs3064744 alleles in the Russian population. [PDF]
Vinokurov MA +3 more
europepmc +1 more source
Correlation of <i>UGT1A1</i> genotypes with newborn hyperbilirubinemia using newborn genetic screening. [PDF]
Ji Q, Zeng W, Li X, Chong S, Zhu J.
europepmc +1 more source
Variants in UGT1A1 and SLCO1B1 increase the risk of neonatal hyperbilirubinemia: a case-control study in subtropical China. [PDF]
Wang WF +4 more
europepmc +1 more source

